(Q41977722)

14 October 2017

Effects of eplerenone on transcriptional factors and mRNA expression related to cardiac remodelling after myocardial infarction (English)

1 reference

14 October 2017

S Enomoto

1

1 reference

14 October 2017

M Yoshiyama

2

1 reference

14 October 2017

T Omura

3

1 reference

14 October 2017

R Matsumoto

4

1 reference

14 October 2017

T Kusuyama

5

1 reference

14 October 2017

S Kim

6

1 reference

14 October 2017

Y Izumi

7

1 reference

14 October 2017

K Akioka

8

1 reference

14 October 2017

H Iwao

9

1 reference

14 October 2017

K Takeuchi

10

1 reference

14 October 2017

J Yoshikawa

11

1 reference

14 October 2017

language of work or name

English

0 references

publication date

29 March 2005

1 reference

14 October 2017

1 reference

14 October 2017

91

1 reference

14 October 2017

12

1 reference

14 October 2017

1595-1600

1 reference

Increased expression of plasminogen activator inhibitor-1 in cardiomyocytes contributes to cardiac fibrosis after myocardial infarction.

14 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769240

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769240

Recent advances in the treatment of heart failure

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769240

Spironolactone abolishes the relationship between aldosterone and plasminogen activator inhibitor-1 in humans

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769240

Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769240

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769240

Alterations in cardiac gene expression during ventricular remodeling following experimental myocardial infarction

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769240

Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769240

Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769240

Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocard

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769240

Aldosterone induces a vascular inflammatory phenotype in the rat heart

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769240

Dominant negative mutant of c-Jun inhibits cardiomyocyte hypertrophy induced by endothelin 1 and phenylephrine

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769240

Effect of a selective aldosterone receptor antagonist in myocardial infarction

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769240

Angiotensin blockade inhibits increased JNKs, AP-1 and NF- kappa B DNA-binding activities in myocardial infarcted rats

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1769240

Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism

18 August 2018

1 reference

12 December 2020

Remodeling of the rat right and left ventricles in experimental hypertension

1 reference

12 December 2020

Inhibition by angiotensin II type 1 receptor antagonist of cardiac phenotypic modulation after myocardial infarction

1 reference

12 December 2020

ACE inhibitor co-therapy in patients with heart failure: rationale for the Randomized Aldactone Evaluation Study (RALES)

1 reference

12 December 2020

Differences in expression of sarcoplasmic reticulum Ca2+-ATPase and Na+-Ca2+ exchanger genes between adjacent and remote noninfarcted myocardium after myocardial infarction

1 reference

12 December 2020

Increased expression of interleukin-1 beta and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload

1 reference

12 December 2020

Elevated circulating levels of C-C chemokines in patients with congestive heart failure

1 reference

12 December 2020

Effects of candesartan and cilazapril on rats with myocardial infarction assessed by echocardiography

1 reference

12 December 2020

NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats

1 reference

12 December 2020

Roles and relationship of macrophages and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the ischemic and reperfused rat heart

1 reference

12 December 2020

Monocyte chemoattractant protein-1 is upregulated in rats with volume-overload congestive heart failure

1 reference

12 December 2020

RISE IN PLASMA CONCENTRATION OF ALDOSTERONE DURING LONG-TERM ANGIOTENSIN II SUPPRESSION

1 reference

12 December 2020

Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade

1 reference

12 December 2020

Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro

1 reference

12 December 2020

Angiotensin II-forming pathways in normal and failing human hearts

1 reference

12 December 2020

Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase in the human heart

1 reference

12 December 2020

Identifiers

DOI

10.1136/HRT.2004.046540

1 reference

release_xr4hniswibetjnwez267wgoq7y

14 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xr4hniswibetjnwez267wgoq7y

24 November 2022

mapped directly with Wikidata item

1 reference

14 October 2017

PubMed publication ID

15797934

1 reference